ABL1 and acute lymphoblastic leukemia: Although genetically distinct from Ph+ ALL, ABL-class ALL has very similar biological, clinical, and prognostic characteristics and, importantly, appears to share with Ph+ ALL excellent sensitivity to TKIs in preclinical studies and clinical case series [18].